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Abstract Introduction: The ease of imaging the retinal vasculature, and the evolving evidence suggesting this*Corresponding au
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94microvascular bed might reflect the cerebral microvasculature, presents an opportunity to investigate
cerebrovascular disease and the contribution of microvascular disease to dementia with fundus cam-
era imaging.
Methods: A systematic review and meta-analysis was carried out to assess the measurement of
retinal properties in dementia using fundus imaging.
Results: Ten studies assessing retinal properties in dementia were included. Quantitative measure-
ment revealed significant yet inconsistent pathologic changes in vessel caliber, tortuosity, and fractal
dimension. Retinopathy was more prevalent in dementia. No association of age-related macular
degeneration with dementia was reported.
Discussion: Inconsistent findings across studies provide tentative support for the application of
fundus camera imaging as a means of identifying changes associated with dementia. The potential
of fundus image analysis in differentiating between dementia subtypes should be investigated using
larger well-characterized samples. Future work should focus on refining and standardizing methods
and measurements.
 2016 Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).95Keywords: Fundus; Dementia; Alzheimer’s disease; Retinal imaging
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1041. Introduction
Dementia poses a major global medical, economic, and
public health challenge [1–3]. Given this worldwide
burden there is currently great interest in finding early and
easily accessible biomarkers of dementia to ultimately aid
prevention. An ideal biomarker for dementia screeningthor. Tel.:---; Fax:---.
mcgrory@ed.ac.uk
16/j.dadm.2016.11.001
blished by Elsevier Inc. on behalf of the Alzheimer’s Associ
licenses/by-nc-nd/4.0/).
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109should be reliable, predictive, reproducible, noninvasive,
simple to perform, and inexpensive [4]. Novel biomarkers,
including structural and functional neuroimaging, genetic
factors, and biochemical analysis of blood and cerebrospinal
fluid, have been examined. Despite this research focus, there
remains an ongoing need for sensitive biomarkers for de-
mentia. Increasingly, studies have found evidence that cere-
brovascular disease and systemic vascular factors such as
type 2 diabetes and hypertension are associated with
increased risk of dementia [5,6]. Alzheimer’s disease
(AD), the most common form of dementia, is known toation. This is an open access article under the CC BY-NC-ND license (http://
1 December 2016  11:02 pm  ce
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231have a vascular component with small-vessel disease, micro-
infarction, and cerebral amyloid angiopathy contributing to
the pathogenesis [6,7]. Despite the evidence of a vascular
component, difficulties in directly visualizing the cerebral
microvasculature in vivo have hindered efforts to
demonstrate the involvement of cerebral vessels in
dementia.
Anatomically and developmentally, the retina is an exten-
sion of the brain [8]. Because of the homology between the
retinal and cerebral microvasculature [9], the retinal vascu-
lature has potential to be used as a proxy measure whereby
the condition of retinal vessels may reflect the condition of
the cerebral vasculature. This has distinct advantages
because of the ease with which the retina can be noninva-
sively visualized and photographed, offering a “window”
to study brain microvascular and neuronal pathology
[10,11]. Different retinal imaging modalities, such as
fundus camera imaging and optical coherence tomography
(OCT), to measure changes in retinal nerve fiber layer and
retinal ganglion cell loss, and fluorescein angiography
have been applied in the management and research of
systemic diseases. Advancements in retinal imaging
technology have led to promising findings, particularly
OCT where a recent review demonstrated that the
measurement of retinal nerve fiber layer thickness, as a
reflection of axonal loss, provides a promising method to
aid in the diagnosis of various neurodegenerative diseases,
including AD [12]. Although all imaging modalities merit
further study, this review chose to focus on the use of fundus
camera imaging.
Retinal microvascular abnormalities in relation to cogni-
tive dysfunction and dementia have been described in review
articles previously [13–15]. These reviews found evidence to
support the hypothesis that retinal microvascular
abnormalities are associated with dementia [14,15] or
cognitive impairment/dementia both in diabetic patients
and the general population [13]. Retinal abnormalities
were most consistently associated with poorer verbal mem-
ory, information processing speed, and executive function in
population-based samples of middle age and older people
[13]. Heringa et al. [14] reported stronger associations be-
tween retinal microvascular changes and dementia in
cross-sectional studies (odds ratio [OR] range, 1.17–5.57)
than in longitudinal studies where no consistent associations
between retinal morphology and dementia or cognitive
impairment were found (OR and hazard ratio [HR] range,
0.77–1.55). Cheung et al. [15] noted that although various
studies have found an association between retinal vascular
changes and dementia, the results across these studies
were variable. The findings were inconclusive because of
heterogeneity of study design in terms of retinal parameters,
imaging methods, and outcomes. These previous reviews
have examined the extent to which retinal properties relate
to cognitive ability and dementia [13–15]. To our
knowledge, no comprehensive review has been published
on the specific utility of fundus camera imaging as aREV 5.4.0 DTD  DADM132_proof method of identifying and measuring a wide range of
retinal changes, specific to dementia and its various
subtypes. For the purposes of this review, we define fundus
imaging as the use of fundus camera photography to
measure, observe, and quantify microvascular retinal
features and abnormalities.
The direct visualization of the retina using fundus imag-
ing offers an opportunity to assess the potential for abnor-
malities and changes in retinal microvasculature to serve
as biomarkers of microvascular pathology in subtypes of de-
mentia. Fundus photography, with high sensitivity, speci-
ficity, and interexamination and intraexamination
agreement [16], is typically used to determine three different
types of retinal properties: retinopathy, variation in vessel
caliber, and changes in the global geometric branching
network [17]. Furthermore, the digital output from modern
camera systems lends itself to image processing methods
for computer-assisted programs to objectively quantify
important features of the retina and its vasculature with
increasing accuracy and reliability [18]. We aimed to
conduct a systematic review of the literature to examine
the application of fundus camera imaging and analysis in de-
mentia, including AD, vascular dementia (VaD), frontotem-
poral dementia, and dementia with Lewy bodies.2. Methods
2.1. Search strategy
Published studies were identified through systematic
searches of the Medical Literature Analysis and Retrieval
System Online (MEDLINE, including work in progress
from 1946), PubMed (from 1950), and the Excerpta Medica
Database (EMBASE, from 1980) for all human studies pub-
lished until March 2016, in all languages. Search filters
included were keyword, title, and abstract information.
The Medical Subject Heading search terms were “retina,”
or “fundus,” or “retinal vasculature,” or “retinal microvascu-
lature,” or “retinal vascular,” or “retinal vessel,” or “retinop-
athy” and in combination with “dementia,” or “Alzheimer,”
or “Lewy bodies,” or “cognition,” or “cognitive”. Articles
with any combination of any of the retinal terms and any de-
mentia or cognition term were reviewed. We also searched
Google Scholar for all studies published before and
including March 2016. References of relevant articles
were hand-searched and a forward citation search was per-
formed to identify further studies.
2.2. Inclusion and exclusion criteria
This review aimed to include all published studies
applying fundus camera imaging to examine the association
between retinal vasculature/retinopathy and any form of de-
mentia. Inclusion criteria were (1) original study; (2) written
in English; (3) assessment of retinal parameters using fundus
imaging; (4) diagnosis of AD, frontotemporal dementia, de-
mentia with Lewy bodies, or VaD; and (5) diagnosis of1 December 2016  11:02 pm  ce
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304dementia based on established criteria such as the National
Institute of Neurological, Communicative Disorders and
Stroke–Alzheimer Disease and Related Disorders Associa-
tion [19].
The following studies were excluded: (1) review studies;
(2) single-case reports; (3) nonhuman research; (4) non-
English language studies; (5) conference presentations or
summaries; (6) studies without details of dementia diagnosis
criteria; and (7) studies examining retinal integrity through a
method other than fundus photography, for example, a laser
Doppler instrument or OCT.305
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3192.3. Data extraction
All identified studies were screened by title and abstract
by two independent reviewers. Irrelevant and duplicate arti-
cles were removed, and the remaining articles were assessed
for agreement with the inclusion and exclusion criteria by
full-text review (Fig. 1). Data extracted from studies at this
stage included title, year of publication, authors, study
aim, study type, number of patients and control subjects,
mean age, diagnostic criteria, participant selection criteria,
method of fundus imaging and image analysis used, results,
and conclusions.Fig. 1. Flow diagram for m
REV 5.4.0 DTD  DADM132_proof 2.4. Statistical analysis
Review Manager Software Version 5.3 (Cochrane, Ox-
ford) and R v. 2.15.2 were used for the meta-analysis of
continuous and categorical outcomes, calculating the sum-
mary estimates including 95% confidence intervals (CIs).
Extracted data (means, standard deviations [SD], and sample
sizes) were used to calculate the mean difference (MD) using
an inverse variance random-effects model. A random-effects
generic inverse variance method was used to plot summary
odds ratios (sORs) and 95% CIs of adjusted ratios for cate-
gorical measures. We tested for heterogeneity between study
results with the c2 test for heterogeneity with an alpha level
for significance set at P5 .05. Stratified analysis was carried
out on dementia subgroups where possible.3. Results
One thousand five hundred sixty-six studies were identi-
fied in the literature search. One additional study was iden-
tified from Google Scholar. Four hundred sixty-nine were
duplicates and were therefore removed. The remaining
1098 were screened by title and abstract only. Of these, 59
were considered to be potentially relevant and were assessed
by full-text review.anuscript selection.
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Table 1
Included studies using fundus imaging methods to examine retinal associations with dementia
Study
Study design and
total sample size
Dementia outcome
number of cases Mean (SD) age* Male (%)
Retinal
measures
Type of
fundus/camera
model Software/grading
One/both
eyes Region measured
Statistical
analysis
Additional
adjustments
Klaver
et al. [20];
Rotterdam
Study
Prospective
population-
based study.
(n 5 1438)
AD (n 5 62
incident
cases)
No AMD 5
80.5 (4.4);
stage
1 5 80 (4.0);
stage 2 5 81.3
(4.5); stage
35 82.2 (5.6);
stage 4 5 84.5
(4.8)
No AMD 5
35.6%;
stage
1 5 32.1%;
stage
2 5 36.4%;
stage
3 5 32.6%;
stage 4 5
31.3%
AMD Topcon
TRV-50VT
fundus camera,
35 field
Grading of fundus
transparencies
according to the
international
classification
system
Not
reported
Macular area Cox
proportional
hazards
regression
analysis
Age, sex,
smoking,
atherosclerosis,
APOE
Baker
et al. [21];
Cardiovascular
Health Study
Population-based
cross-sectional
study (n 5 2211)
AD (n 5 99);
VaD (n 5 11);
mixed AD
VaD (n 5 49);
other types
(n 5 5)
78 40% Retinopathy;
AVN; FAN;
retinal
vascular
caliber
Canon
CR-45UAF,
nonmydriatic
fundus camera,
45 field
Observer graded.
Caliber was
measured and
summarized
One (50%
right, 50%
left)
Centered between
the OD and
macula. Caliber
measured one
disc diameter
from the OD
margin
ANCOVA;
logistic
regression
Age, sex, race,
field center,
education,
internal
carotid
intimamedia
thickness,
weight,
hypertension,
diabetes,
smoking,
cerebral
MRI signs
Baker
et al. [22];
Cardiovascular
Health Study
Population-based
cross-sectional
study (n 5 2088)
Dementia
(n 5 135);
AD (n 5 86)
With
AMD: 80
(4.7); no
AMD: 78
(4.2)
With
AMD:
41%;
no
AMD
39.7%
AMD Canon
CR-45UAF,
nonmydriatic
fundus camera,
45 field
Observer graded. One (50%
right, 50%
left)
Grading was
performed by
the superimposition
of a circular grid
over the macular
area
Logistic
regression
Age, sex,
ethnicity,
study center,
education,
systolic BP,
total cholesterol
level, diabetes,
smoking, APOE
Qiu et al. [23];
AGES-
Reykjavik
Study
Population-based
cross-sectional
study (n 5 3906)
AD (n 5 66);
VaD (n 5 31);
possible AD
and VaD
(n 5 20)
76 42% Retinopathy;
AVN; FAN,
6.3-Megapixel
Canon CR6
nonmydriatic
camera; 45 field
Observer graded Both Two images,
centered on
the OD and the
macula
Linear
regression;
logistic
regression
Age, sex, education,
visual acuity,
depressive
symptoms,
smoking,
hypertension,
diabetes, BMI,
use of
anticoagulants,
brain infarcts,
load of
subcortical
and
periventricular
white matter
hyperintensities,
cerebral
microbleeds
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De Jong
et al. [24];
Rotterdam
Study
Population-based
prospective study
(n 5 5553)
Incident
dementia: AD
(n 5 519); VaD
(n 5 73); other
subtypes (n5 63)
68 41% CRVE;
CRAE
Topcon, 20
field
Retinal Vessel
Measurement
System
One (best
quality
image of
either eye)
Centered on
the OD
Cox
proportional
hazards
models
Age, sex, systolic
BP,
antihyperintensive
medication,
serum total
cholesterol,
serum C-reactive
protein,
smoking,
diabetes mellitus,
coronary heart
disease, stroke,
CRAE/CRVE
adjusted for
fellow vessel
caliber
Schrijvers
et al. [25];
Rotterdam
Study
Population-
based
cross-sectional
and prospective
study
(n 5 6078)
AD (n 5 149); VaD
(n 5 29); other
subtypes (n5 17)
69 41% Retinopathy Topcon
TRV-50VT,
35 field
Observer
graded
Both Centered on the
macula
Logistic
regression;
Cox
proportional
hazards
models
Age, sex, stroke,
systolic BP, use
of antihypertensive
medication,
education,
smoking,
diabetes, total
cholesterol,
C-reactive
protein, coronary
heart disease,
APOE
Frost
et al. [26];
Australian
Imaging,
Biomarkers
and Lifestyle
(AIBL)
Flagship
Study of
Ageing
Case-control
study
(n 5 25:123)
AD (n 5 25) Control:
71.6;
AD:
72.4
Control:
45%;
AD:
48%
CRAE;
CRVE;
AVR; FD;
BSTD; BC;
AF; JE;
LDR;
tortuosity;
Num1stB
Canon CR-1
nonmydriatic
camera, 45
field
SIVA Not
reported
Centered on OD;
0.5–1.0 disc
diameters or
0.5–2.0 disc
diameters away
from the
disc margin
ANCOVA;
receiver-
operating
characteristic
(ROC) curve
analysis
Age, sex,
hypertension,
diabetes,
smoking, APOE
Cheung
et al., 2014
Singapore
Epidemiology
of Eye
Disease
(SEED)
program
Case-control
study (n 5
136:290)
AD (n 5 136) Control:
73.9;
AD:
74.8
Control:
53%;
AD:
47%
CRAE;
CRVE; FD;
tortuosity;
BA
Canon CR-DGi
10D or Canon
CR-1 40D,
45 field
SIVA Both Two images of
each eye: one
centered at the
OD and the other
centered at the
fovea.
Measurements
taken between
0.5 and 2.0 disc
diameters away
from the disc margin
Independent t
test or c2
test; logistic
regression
Age, sex, ethnicity, Q11
smoking,
hypertension, Q12
hypercholesterolemia,
diabetes, history
of myocardial
infarction,
CRAE/CRVE
adjusted for
fellow vessel
caliber
Williams et al.
[27]
Case-control study
(n 5 258:322)
AD (n 5 258) Control:
76.6;
AD: 80.1
Control:
39%;
AD: 37%
AMD Slit-lamp
mounted
Canon CR-DGi
Observer
graded
One (grade
from worst
eye or from
only gradable
image)
6000 mm AREDS grid
centered on
fovea
Logistic
regression
Age, smoking,
recent illness,
APOE
(Continued)
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Table 1
Included studies using fundus imaging methods to examine retinal associations with dementia (Continued)
Study
Study design and
total sample size
Dementia outcome
number of cases Mean (SD) age* Male (%)
Retinal
measures
Type of
fundus/camera
model Software/grading
One/both
eyes Region measured
Statistical
analysis
Additional
adjustments
Williams et al.
[28]
Case-control study
(n 5 213:294)
AD (n 5 213) Control:
76.3;
AD: 79.6
Control: 40%;
AD: 36%
CRAE;
CRVE; FD;
tortuosity BA
500 Canon
CR-DGi
SIVA One (right image
were available,
otherwise left)
0.5 and 2.0 disc
diameters away
from the disc margin
independent
t test or c2 test;
logistic
regression
Age, sex, mean
arterial BP,
smoking,
hypercholesterolemia,
diabetes mellitus,
history of
cardiovascular
disease,
cerebrovascular
disease,
medications
(aspirin/clopidogrel,
beta blockers,
calcium channel
blockers, diuretics,
nonsteroidal
antiinflammatory
drugs, thyroxine),
CRAE/CRVE
adjusted for fellow
vessel caliber
Abbreviations: AD, Alzheimer’s disease; AF, asymmetry factor; AMD, age-related macular degeneration; ANCOVA, analysis of covariance; APOE, apolipoprotein E; AREDS, Age-Related Eye Disease Study;
AVN, arteriovenous nicking; AVR, arteriole-to-venule ratio Q13; BA, branching angle; BC, branching coefficient; BMI, body mass index; BP, blood pressure; BSTD, zone B standard deviation; CRAE/CRVE, central
retinal arterial/venular equivalent; FAN, focal arteriolar narrowing; FD, fractal dimension; JE, Junctional exponent deviation; LDR, length to diameter ratio; MRI, magnetic resonance; Num1stB, number of first
Q14
branching vessels in zone C; OD, optic disc; SD, standard deviation; SIVA, Singapore I Vessel Assessment; VaD, vascular dementia.
*For longitudinal studies age at baseline.
R
E
V
5
.4
.0
D
T
D

D
A
D
M
1
3
2
_p
ro
o
f

1
D
ecem
b
er
2
0
1
6

1
1
:0
2
p
m

ce
S
.
M
cG
ro
ry
et
a
l.
/
A
lzh
eim
er’s
&
D
em
en
tia
:
D
ia
g
n
o
sis,
A
ssessm
en
t
&
D
isea
se
M
o
n
ito
ring
-
(2
0
1
6
)
1
-1
7
6
5
9
8
5
9
9
6
0
0
6
0
1
6
0
2
6
0
3
6
0
4
6
0
5
6
0
6
6
0
7
6
0
8
6
0
9
6
1
0
6
1
1
6
1
2
6
1
3
6
1
4
6
1
5
6
1
6
6
1
7
6
1
8
6
1
9
6
2
0
6
2
1
6
2
2
6
2
3
6
2
4
6
2
5
6
2
6
6
2
7
6
2
8
6
2
9
6
3
0
6
3
1
6
3
2
6
3
3
6
3
4
6
3
5
6
3
6
6
3
7
6
3
8
6
3
9
6
4
0
6
4
1
6
4
2
6
4
3
6
4
4
6
4
5
6
4
6
6
4
7
6
4
8
6
4
9
6
5
0
6
5
1
6
5
2
6
5
3
6
5
4
6
5
5
6
5
6
6
5
7
6
5
8
6
5
9
6
6
0
6
6
1
6
6
2
6
6
3
6
6
4
6
6
5
6
6
6
6
6
7
6
6
8
6
6
9
6
7
0
6
7
1
6
7
2
6
7
3
6
7
4
6
7
5
6
7
6
6
7
7
6
7
8
6
7
9
6
8
0
6
8
1
6
8
2
6
8
3
6
8
4
6
8
5
6
8
6
6
8
7
6
8
8
6
8
9
6
9
0
6
9
1
6
9
2
6
9
3
6
9
4
6
9
5
6
9
6
6
9
7
6
9
8
6
9
9
7
0
0
7
0
1
7
0
2
7
0
3
7
0
4
7
0
5
7
0
6
7
0
7
7
0
8
7
0
9
7
1
0
7
1
1
7
1
2
7
1
3
7
1
4
7
1
5
7
1
6
7
1
7
7
1
8
7
1
9
Table 2
Retinal parameters assessed by reviewed studies
Retinal measure Description Study
Age-related macular degeneration (AMD) Degenerative disorder of the macula characterized generally by extensive
drusen, often associated with pigmentary abnormalities (Coleman
et al., 2008*)
Klaver et al., 1991 Q15; Baker et al. [22]; Williams et al. [27]
Retinopathy Disease of the retina that results in impairment or loss of vision-symptoms
include microaneurysms, hemorrhages, hard exudates, and cotton
wool spots
Baker et al. [21]; Qiu et al. [23]; Schrijvers et al. [25]
Focal arteriolar narrowing (FAN) Presence of localized areas of arteriolar constriction—definite: arteriole
40 mm in diameter and250 mm in length, with caliber of constricted
area 1/2 that of proximal and distal segment; probable: constricted
vessel ,40 mm in diameter or ,250 mm in length (Qiu et al., 2009y)
Baker et al. [21]; Qiu et al. [23]
Arteriovenous nicking Arteriole crossing a venule resulting in the compression of the venule with
bulging on either side of the crossing. Definite: tapering or narrowing
of the venule on three or four sides of the crossing; probable: narrowing
on only two sides of the crossing (Qiu et al., 2009y)
Baker et al. [21]; Qiu et al. [23]
Central retinal arteriolar equivalent caliber (CRAE) Summary measures of vascular equivalent caliber representing the
equivalent single-vessel parent width for the six largest arterioles and
venules. Based on the Knudston-Parr-Hubbard formula (Knudston
et al., 2003 Q16)
de Jong et al. [24]; Frost et al. [26]; Cheung et al., 2014; Williams
et al. [28]Central retinal venular equivalent (CRVE) caliber
Arteriole to venular ratio (AVR) The ratio between summarized arteriolar caliber measurement (CRAE)
with respect to the summarized venular caliber (CRVE). CRAE/
CRVE 5 AVR
Frost et al. [26]
Fractal dimension of arteriolar network (FDa) Global summary measure of branching complexity of the retinal vascular
tree reflecting how thoroughly the branching pattern fills two-dimensional
spaces. Larger values represent a more complex pattern. Calculated from
the skeletonized line tracing using the box-counting method
Frost et al. [26]; Cheung et al., 2014; Williams 2015 [28]
Fractal dimension of venular network (FDv)
Curvature tortuosity arteriole Integral of the curvature squared along the vessel path, normalized by the
total path length. Measurements are summarized to represent the average
tortuosity of arterioles and venules separately with smaller values
reflecting straighter vessels
Frost et al. [26]; Cheung et al., 2014; Williams et al. [28]
Curvature tortuosity venule
Number of first branching arterioles The number of arterioles and venules with a first bifurcation, branch, or
daughter vessel, in zone C
Frost et al. [26]
Number of first branching venules
Branching coefficient arteriole Calculated from average Num1st (number of first branching vessels)
measurements. Branching coefficient reflects the relationship between
parent vessels and branches. Defined as the summed square of the mean
vessel widths of each branch or daughter vessel divided by the square of
the mean width of the parent vessel
Frost et al. [26]
Branching coefficient venule
Junctional exponent deviation for arterioles Calculated from average Num1st measurements. Junctional exponent
deviation reflects the deviation from the optimum ratio of vessel widths at
a bifurcation
Frost et al. [26]
Junctional exponent deviation for venules
Length to diameter ratio arteriole (LDRa) Length to diameter ratio is the length of the vessel from the midpoint of
one bifurcation to the midpoint of the next bifurcation. It is expressed as a
ratio to the diameter of the parent vessel at the first bifurcation
Frost et al. [26]
Length to diameter ratio venular (LDRv)
*Coleman HR, Chan CC, Ferris FL, Chew EY. Age-related macular degeneration. The Lancet 2003;372 (9652):1835–45.
yQiu C, Cotch MF, Sigurdsson S, Klein R, Jonasson F, Klein BE, et al. Microvascular lesions in the brain and retina: the age, gene/environment susceptibility—Reykjavik Study. Annals of Neurology 2009;65
(5):569–76.
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Table 3
Associations between retinal parameters measured using fundus imaging and dementia in cross-sectional studies
Study
Dementia
outcome
Focal arteriolar narrowing, arteriovenous nicking, and retinal vessel caliber FD, tortuosity, branching pattern and geometry
Retinopathy* AMD* FAN* AVN* CRAE CRVE AVR
FD Tortuosity
BA
BC AF
a v a v a v a v
OR (95% CI) or direction of association
Baker
et al. [21]
Dementia 1.17 (0.62–2.22) . 1.99
(1.11–3.56)
1.48
(0.74–2.96)
1.42
(0.74–2.73 Q17)z
5y . . . . . . . . . .
Mixed AD
VaD
3.57
(1.31–9.75)
AD 1.38
(0.64–2.97)
Baker
et al. [22]
Dementia . 0.98
(0.57–1.69)
. . . . . . . . . . . . . .
AD 1.09
(0.57–2.08)
Qiu
et al. [23]
Dementia 1.35 (0.89–2.04) . 5 5 . . . . . . . . . . . .
AD 1.22 (0.73–2.04)
VaD 1.95 (1.04–3.62)
Schrijvers
et al. [25]
Dementia 1.92 (1.24–2.98) . . . . . . . . . . . . . . .
AD 1.89 (1.15–3.10)
VaD 2.00 (0.71–5.63)
Frost
et al. [26]
AD . . . . 2 2 5 2 2 5 2 5 5 1 1 1
Cheung
et al., 2014
AD . . . . 2 2 . 2 2 1 1 5 . . . .
1.22
(0.78–1.91)
2.01
(1.27–3.19)
1.35
(1.08–1.68)
1.47
(1.17–1.84)
1.8
(1.48–2.53)
1.94
(1.48–2.53)
Williams
et al. [28]
AD . . . . 1 5 . 2 2 2 5 5 . . . .
1.11
(0.83–1.47)
0.99
(0.75–1.32)
0.92
(0.74–1.14)
0.77
(0.62–0.97)
0.78
(0.63–0.97)
1.01
(0.82–1.24)
Williams
et al. [27]
AD . 5 . . . . . . . . . . . . . .
Abbreviations: a, arteriolar; AD, Alzheimer’s disease; AF, asymmetry factor; AMD, age-related macular degeneration; AVN, arteriovenous nicking; AVR, arteriole-to-venule ratio; BA, branching angle; BC,
branching coefficient; CI, confidence intervals; CRAE/CRVE, central retinal arterial/venular equivalent; FAN, focal arteriolar narrowing; FD, fractal dimension; OR, odds ratio; v, venular; VaD, vascular demen-
tia;., outcome measure not evaluated; 5, no association between presence of retinal parameter and outcome measure.
NOTE. Results for vessel caliber were recorded in such a way that a negative coefficient means narrowing is associated with dementia, positive coefficient means widening is associated with dementia.
*Measure dichotomized: present versus absent.
yRetinal vessel caliber not measured using CRAE/CRVE; caliber categorized into quintiles, result reported for first quintile; results for FD/tortuosity/BA/BC/AF presented such that a negative coefficient means
reduced retinal parameter is associated with AD, positive coefficient means increased retinal parameter associated with AD. Bold values indicate significant associations Q18.
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1017
1018
1019
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1021
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1024
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1026
1027
1028
1029
1030
1031
1032Ten studies met the inclusion criteria. The populations
sampled came from the US (2), UK (2), Iceland (1), the
Netherlands (3), Australia (1), and Singapore (1). Multiple
articles from the same study population were included
only if different retinal properties or outcome measures
were examined in separate articles. Table 1 describes the
characteristics of the studies reviewed.1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
10463.1. Study design and population
The 10 studies included comprised three prospective
cohort studies [20,24,25], three population-based cross-
sectional studies [21–23], and four case-control studies
[10,26–28]. Although several articles had overlapping
samples, each article assessed different retinal features.
These articles were therefore all included. Across the 10
studies the number of unique participants (i.e., without
overlap across studies) was 13,349. The number of
dementia cases per article varied from 25 to 655 [24,28].
Table 1 describes the characteristics of the studies reviewed.Q5 1047
1048
1049
1050
1051
1052
1053
1054
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
1066
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
10853.2. Measurement
Studies assessed retinal parameters through visual
grading or with the application of computer-assisted pro-
grams. Retinopathy, arteriovenous nicking (AVN), focal
arteriolar narrowing (FAN), and age-related macular degen-
eration (AMD) were visually graded. Definitions and
grading of retinopathy differed across studies. Retinopathy
was identified by three ophthalmologically trained physi-
cians in the Rotterdam Study by the presence of one or
more dot/blot hemorrhages, microaneurysms, or cotton
wool spots or evidence of laser treatment for retinopathy
[25]. The Cardiovascular Health Study examined images
for signs of microaneurysms, retinal hemorrhages, cotton
wool spots, hard exudates, macular edema, intraretinal
microvascular abnormalities, venous beading, new vessels
at the disc or elsewhere, and vitreous hemorrhage [21]. Reti-
nopathy was identified by three certified graders in the
AGES-Reykjavik Study on the basis of presences of retinal
blot hemorrhages, microaneurysms, soft exudates, and other
less common lesions such as hard exudates, macular edema,
and optic disc swelling [23]. AMDwas identified and graded
according to the international classification grading systems
[29,30] by Baker et al. [22] and Williams et al. [27].
Quantitative retinal measurements performed using
computer-assisted methods included central retinal arterial
equivalent (CRAE); central retinal venular equivalent
(CRVE); arteriovenous ratio (AVR); SD of vessel width
in zone B (BSTD); length to diameter ratio (LDR); curva-
ture tortuosity; bifurcation angle; junctional exponent devi-
ation; fractal dimension (FD); number of first branching
arterioles; branching coefficient (BC); and asymmetry fac-
tor. Most studies assessed vessel width as continuous vari-
ables. See Table 2 for definitions of retinal parameter
terminology.REV 5.4.0 DTD  DADM132_proof Retinal photographs were taken after pharmacological
pupil dilation, except in the Australian Imaging, Biomarkers
and Lifestyle Flagship Study of Ageing [26] where images
were taken using a nonmydriatic camera in a darkened
room and in the Cardiovascular Health Study [21,22] in
which images were taken after 5 minutes of dark
adaptation. Methods of fundus photography and image
analysis varied across studies (see Table 1).
Singapore “I” Vessel Assessment (SIVA) software was
used to automatically extract retinal vascular structure and
calculate quantitative measures from retinal images in three
studies [10,26,28]. Quantitative measurement in the
Rotterdam Study [24] was performed using Retinal Vessel
Measurement System. The remaining studies used observer
grading methods [20–23,25,27].3.3. Associations between retinal parameters and
dementia
Associations between retinal parameters and dementia
outcomes are presented in Tables 3 and 4. These tables
report results adjusted for demographics and vascular risk
factors (details of adjustments are provided in Table 1). Re-
sults from cross-sectional and prospective cohort studies are
presented separately. Associations of increased retinal
parameter values with dementia were indicated by “1,” as-
sociations of decreased retinal parameter values with de-
mentia were indicated by “2,” and no statistically
significant association between retinal parameters and de-
mentia was indicated by “5.” In text both uncorrected and
adjusted results are provided where possible.3.4. Cross-sectional studies: Retinopathy and AMD3.4.1. Retinopathy
Neither the Cardiovascular Health Study [21] nor the
AGES-Reykjavik Study [23] found an association between
retinopathy and dementia in uncorrected (OR, 1.34; 95%
CI, 0.90–1.99 [data not provided in the Cardiovascular
Health Study]) or multivariate-adjusted models (OR, 1.17;
95% CI, 0.62–2.22; OR, 1.35; 95% CI, 0.89–2.04, respec-
tively) in all subjects. In stratified multivariable models,
among persons with hypertension, retinopathy was associ-
ated with dementia (OR, 2.10; 95% CI, 1.04–4.24). No asso-
ciation was found in those without hypertension [21].
Analyses stratified by diabetes status found an association
between retinopathy and dementia in those without diabetes
(OR, 1.96; 95% CI, 0.96–4.02). No association was found in
those with diabetes (OR, 0.32; 95% CI, 0.07–1.44) [21].
Schrijvers et al. [25] found a significant association
between retinopathy and dementia in a population-based sam-
ple of individuals aged 55 years and older (age and sex–
adjusted OR, 2.04; 95% CI, 1.34–3.09) with a multivariable-
adjusted OR 5 1.92 (95% CI, 1.24–2.98). sOR of dementia
in the presence versus absence of retinopathy was 1.42 (95%1 December 2016  11:02 pm  ce
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Table 4
Associations between retinal parameters and dementia in longitudinal studies Q19
Study Dementia outcome
AMD Retinopathy
Vessel caliber
CRAE CRVE
RR (95% CI) HR (95% CI)
Schrijvers et al. [25] Dementia 1.15 (0.89–1.50)
AD 1.15 (0.86–1.55)
VaD 0.90 (0.39–2.11)
De Jong et al. [24] Dementia 1.05 (0.96–1.16) 1.11 (1.00–1.22)
AD 1.02 (0.91–1.14) 1.06 (0.95–1.19)
VaD 1.33 (0.99–1.78) 1.44 (1.10–1.89)
Klaver et al. [20] AD 1.5 (0.6–3.5)
Abbreviations: AD, Alzheimer’s disease; AMD, age-related macular degeneration; CI, confidence interval; CRAE/CRVE, central retinal arterial/venular
equivalent; HR, hazard ratio; RR, relative risk; VaD, vascular dementia.
NOTE. Bold values indicate significant associations.
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1174CI, 1.10–1.85; Fig. 2), with the 95% CI from two studies
crossing zero. There was no significant heterogeneity between
the three articles (c2 P 5 .37).
The cross-sectional AGES-Reykjavik Study found that
those with retinopathy lesions had an increased risk of
VaD (age, sex, and education–adjusted OR, 1.98; 95% CI,
1.10–3.56; multivariate-adjusted OR, 1.95; 95% CI, 1.04–
3.62) but not AD (age, sex, and education–adjusted OR,
1.20; 95% CI, 0.73–1.98; multivariate-adjusted OR, 1.22;Fig. 2. Meta-analysis providing unadjusted summary odds ratios (sORs) showin
vascular dementia (VaD). The size of the square denotes the weight attributed to
(CI). A diamond represents sOR with the width representing the 95% CI. Abbrev
REV 5.4.0 DTD  DADM132_proof 95% CI, 0.73–2.04) [23]. The Rotterdam Study found
increased risk of AD with retinopathy (age and sex–adjusted
OR, 1.80; 95% CI, 1.11–2.91; multivariate-adjusted OR,
1.89; 95% CI, 1.15–3.10). The association between retinop-
athy and VaD (OR, 3.01; 95% CI, 1.26–7.21) did not persist
after full adjustment (OR, 2.0; 95% CI, 0.71–5.63) [25].
Retinopathy was not significantly associated with AD or
“mixed” AD VaD when assessed separately in the Cardio-
vascular Health Study (data not reported in study article)g association of retinopathy and dementia, Alzheimer’s disease (AD) and
each article, and the horizontal lines represent the 95% confidence interval
iation: SE, standard error.
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1295[21]. sOR of AD and VaD in retinopathy was 1.53 (95% CI,
0.99–2.34; Fig. 2) and 1.96 (95% CI, 1.15–3.35; Fig. 2),
respectively, with no significant heterogeneity between arti-
cles (c2 P 5 .23; 0.97).
3.4.2. Age-related macular degeneration
Williams et al. [27] found an association between the
most advanced cases of AMD (grade 3: geographic atrophy
or neovascular AMD) and AD when uncorrected (OR, 2.5;
95% CI, 1.3–5.0) [27]. The association was lost following
adjustment for potential confounding variables (age, smok-
ing, APOE, and recent illness) (OR, 1.38; 95% CI, 0.6–
3.2). Earlier stages of AMD were not associated with AD
in unadjusted (data not provided) or adjusted models (grade
1: OR, 0.65; 95% CI, 0.4–1.1; grade 2: OR, 1.00; 95% CI,
0.5–1.9).
Early AMD (presence of soft drusen/retinal pigment
epithelial depigmentation/combination of soft drusen with
increased retinal pigment/depigmentation in the absence of
exudative AMD/pure geographic atrophy) was not associated
with dementia (adjusted for age, sex, ethnicity, study center:
OR, 0.77; 95% CI, 0.47–1.27; fully adjusted model: OR,
0.98; 95% CI, 0.57–1.69) or AD (OR, 0.81; 95% CI, 0.45–
1.48 and OR, 1.09; 95% CI, 0.57–2.08) [22]. Late AMD
was not assessed because of the rarity of these lesion types.1296
1297
1298
1299
1300
1301
1302
13033.5. Longitudinal studies: Retinopathy and AMD
Retinopathy and AMD in relation to incident dementia 2
to 11 years later was examined (see Table 4). Retinopathy
was not significantly associated with increased risk of de-
mentia (age and sex–adjusted HR, 1.15; 95% CI,Fig. 3. Meta-analysis of Alzheimer’s disease (AD) versus control subjects: CRA
article, and the horizontal lines represent the 95% confidence interval (CI). A dia
the 95% CI. Unadjusted results reported. Abbreviations: CRAE, central retinal art
viation.
REV 5.4.0 DTD  DADM132_proof 0.88–1.48; multivariate-adjusted HR, 1.15; 95% CI, 0.89–
1.50), AD (age and sex–adjusted HR, 1.12; 95% CI, 0.83–
1.50; multivariate-adjusted HR, 1.15; 95% CI, 0.86–1.55),
or VaD (age and sex–adjusted HR, 0.97; 95% CI, 0.42–
2.23; multivariate-adjusted HR, 0.90; 95% CI, 0.39–2.11)
after a follow-up of 11.6 years [25]. Klaver et al. [20] found
an increased risk of incident AD after 25.2 months in those
with advanced stage AMD (indistinct or reticular drusen
with pigmentary irregularities/the presence of either atro-
phic or neovascular end-stage macular degeneration) at
baseline (age and sex–adjusted relative risk [RR], 2.1;
95% CI, 1.1–4.3). However, the association was attenuated
following adjustment for smoking and atherosclerosis (RR,
1.5; 95% CI, 0.6–3.5). Risk of AD did not increase for those
with earlier AMD in age and sex–adjusted model (RR, 1.0;
95% CI, 0.6–1.9) or following adjustment for smoking and
atherosclerosis (RR, 1.0; 95% CI, 0.6–3.5).3.6. Cross-sectional studies: Retinal vascular caliber,
FAN, or AVN
Associations between arteriolar widths and dementia
were inconsistent (see Table 3). Using CRAE as a summary
measure of vessel caliber, Frost et al. [26] and Cheung et al.
[10] found arteriolar narrowing in AD (area under the curve
[AUC] 5 0.612, SD 5 0.082; age, sex, and ethnicity–
adjusted OR, 2.02; 95% CI, 1.59–2.58, respectively),
whereas Williams et al. [28] found evidence of arteriolar
widening in AD (age and sex–adjusted OR, 1.37; 95% CI,
1.08–1.75). However, associations were lost once cardiovas-
cular risk factors were controlled for OR, 1.22; 95% CI,
0.78–1.91 [10] and OR, 1.1; 95% CI, 0.83–1.47 [28].E and CRVE. The size of the square denotes the weight attributed to each
mond represents the summary mean difference with the width representing
erial equivalent; CRVE, central retinal venular equivalent; SD, standard de-
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1451Meta-analysis of the three studies found a reduction in
arteriolar width in AD using CRAE (MD, 27.52; 95%
CI,218.88 to 3.84; Fig. 3) with significant heterogeneity be-
tween articles (c2 P , .001). The Cardiovascular Health
Study failed to find a significant association between arteri-
olar caliber and dementia (multivariate-adjusted OR, 1.42;
95% CI, 0.74–2.96) [21]. Different measures of arteriolar
caliber were also applied by Frost et al. [26]. Increasing
SD of arteriolar widths (AUC 5 0.595, SD 5 0.070,
P 5 .0086) and arteriolar attenuation (AUC 5 0.651,
SD 5 0.068, P 5 .049) in AD was found using a measure
of the SD of arteriolar width in zone B (BSTDa) and arteri-
olar LDR.
Associations between venular caliber and dementia were
also mixed (see Table 3). Frost et al. [26] found evidence of
narrower venular widths in AD using CRVE (AUC5 0.703,
SD5 0.067, P5 .0049) and increasing SD of venular widths
(AUC 5 0.541, SD 5 0.081, P 5 .0089) using BSTDv.
Cheung et al. [10] also found that patients with AD
(n 5 136) had narrower venular calibers measured using
CRVE (P , .001; age, sex, and ethnicity–adjusted OR,
2.17; 95% CI, 1.69–2.79; multivariate-adjusted OR, 2.01,
95%CI, 1.27–3.19). Williams et al. [28] did not find a signif-
icant difference between CRVE in patients with AD
(n 5 213) and control subjects (n 5 294) (d 5 0.006,
P 5 .951) (multivariable-adjusted OR, 0.99; 95% CI,
0.75–1.32, P5 .960). Although not wholly consistent, there
was a general reduction in venular calibers in AD using
CRVE (MD, 210.74; 95% CI, 224.09 to 2.61; Fig. 3)
with significant heterogeneity between articles (c2
P, .001). Using venular LDR Frost et al. [26] found no dif-
ference in caliber between AD and control subjects
(P . .05). The only study using AVR found no significant
difference between patients with AD and the control group
(P . .05) [26].REV 5.4.0 DTD  DADM132_proof Neither study examining the association between AVN
and dementia found any significant associations (multivari-
able-adjusted OR, 1.48; 95% CI, 0.74–2.96) [21] (data not
provided) [23].
FAN associations were mixed (see Table 3). Although
Qiu et al. [23] failed to find an association of FAN with de-
mentia (data not provided), the Cardiovascular Health Study
found a relationship (multivariate-adjusted OR, 1.99; 95%
CI, 1.11–3.56) that appeared to be driven by hypertension
and diabetes [21]. Those with evidence of FAN were more
likely to have “mixed AD VaD” (OR, 3.57; 95% CI, 1.31–
9.75) but not AD (OR, 1.38; 95% CI, 0.64–2.97).3.7. Longitudinal studies: Retinal vascular caliber, FAN,
or AVN
The prospective Rotterdam Study examined associations
between retinal vascular calibers and incident dementia, AD
(with or without cerebrovascular disease), and VaD [24]
(Table 4). Increased risk of dementia with retinal venular
widening was found (age and sex–adjusted HR, 1.09; 95%
CI, 1.01–1.18; multivariate-adjusted HR, 1.11; 95% CI,
1.00–1.22) [24]. Stratified analyses revealed the increased
risk was driven by the association with VaD (n 5 73) (HR,
1.31; 95% CI, 1.06–1.64; multivariate-adjusted HR, 1.44;
95% CI, 1.10–1.89). Venular width was not significantly
associated with increased risk of AD in stratified analyses
following exclusion of those with cardiovascular disease
(n 5 47) (HR, 1.16; 95% CI, 0.82–1.64).
No association of arteriolar width with risk of dementia
(HR, 0.99; 95% CI, 0.91–1.07), AD (HR, 0.98; 95% CI,
0.89–1.14), or VaD (HR, 1.06; 95% CI, 0.84–1.33) was found
in age and sex–adjusted models [24]. Narrower arterioles
were related to an increased risk of VaD but only after adjust-
ment for venular calibers (HR, 1.40; 95% CI, 1.05–1.86).1 December 2016  11:02 pm  ce
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15733.8. Cross-sectional studies: FD, branching pattern, and
geometry
Three articles examined the link between FD and AD
[10,26,28], each reporting a reduction in arteriolar and
venular FD indicating a sparser network in AD
(MD,20.02; 95% CI,20.03 to20.01) (Fig. 4) with no sig-
nificant heterogeneity between articles (arteriolar FD c2
P 5 .26; venular FD c2 P 5 .21). Patients with AD demon-
strated reduced complexity of the branching pattern in com-
parison with control subjects with lower arteriolar
(AUC 5 0.644, SD 5 0.075, P 5 .021) and venular FDs
(AUC 5 0.716, SD 5 0.074, P 5 .0033) [26]. A smaller
number of first branching vessels in zone C were found in
AD (arteriolar; AUC 5 0.675, SD 5 0.142, P 5 .022; ven-
ular; AUC 5 0.660, SD 5 0.121), again indicating reduced
complexity of branching [26]. Reduced FD in patients with
AD with significant results for venular (d 5 0.4, P 5 .001;
multivariate-adjusted OR per SD decrease, 1.47; 95% CI,
1.17–1.84), arteriolar (d 5 0.3, P 5 .002; OR, 1.35, 95%
CI, 1.08–1.68), and total FD (d 5 0.4, P , .001; OR, 1.54;
95% CI, 1.23–1.93) was also found in the Singapore Epide-
miology of Eye Disease study [10]. Likewise, Williams et al.
[28] found significantly lower fractal total (d 5 0.3,
P 5 .001), arteriolar (d 5 0.2, P 5 .024), and venular
(d 5 0.4, P , .001) dimensions in AD. Those with lower
venular FD (multivariate-adjusted OR per SD increase,
0.77; 95% CI, 0.62–0.97, P 5 .025) were more likely to
have AD. The association between total and arteriolar FD
and AD did not persist in the final models (OR, 0.85; 95%
CI, 0.68–1.06, P 5 .141; OR, 0.92; 95% CI, 0.74–1.14,
P 5 .436).
Neither study examining branching angle found a differ-
ence in arteriolar or venular angle between AD and control
groups (d5 0.07, P5 .521; d5 0.01, P5 .922, respectively)
[10] (d5 0.006, P5 .523; d5 0.04, P5 .599, respectively)
[28]. Another measure of circulatory optimality, junctional
exponent deviation, also failed to identify an association be-
tween AD and branching angles (data not provided) [26].
Higher venular BC values in AD (AUC 5 0.55,
SD 5 0.084, P 5 .035), indicating reduced optimality of
branching geometry, were found [26]. Further evidence of
reduced branching geometry optimality with greater arteri-
olar and venular asymmetry factor values in AD
(AUC 5 0.578, SD 5 0.081, P 5 .037; AUC 5 0.616,
SD 5 0.074, P 5 .047, respectively) was found [26].
Inconsistent associations between tortuosity and dementia
were found [10,26,28] (see Table 3). More tortuous arterioles
and venules were observed in AD than in control subjects
(d 5 0.2, P , .001) in the Singapore Epidemiology of Eye
Disease study [10]. Those with higher arteriolar and venular
tortuosity were more likely to have AD (multivariable-
adjusted OR per SD increase, 1.8; 95% CI, 1.48–2.53; OR,
1.94; 95% CI, 1.48–2.53, respectively). Frost et al. [26] found
less tortuous venules (AUC5 0.706, SD5 0.073, P5 .042)
inADwith no significant difference in arteriolar tortuosity be-REV 5.4.0 DTD  DADM132_proof tween patients with AD (n5 25) and healthy control subjects
(n 5 123) (data not provided). Conversely, Williams et al.
[28] found lower arteriolar tortuosity in AD (d 5 0.2,
P 5 .030, multivariable-adjusted OR, 0.78; 95% CI, 0.63–
0.97, P 5 .27), and not venules (d 5 0.07, P 5 .458).4. Discussion
The aim of this review was to assess the relationship be-
tween microvascular changes in the retina and dementia
with the use of fundus camera imaging. Despite consider-
able heterogeneity in both retinal parameters and study
design, the cross-sectional studies reviewed found evi-
dence of some consistent cross-sectional associations
with dementia. The heterogeneity of retinal measurements
in the few longitudinal studies included in this review pre-
cluded the comparison of findings across prospective
studies.
The most consistent finding was decreased FD in AD
[10,26,28]. A decreased FD indicating a sparser
branching density has also been observed in stroke
[31,32], cognitive dysfunction [33], and hypertension
[18]. Pathophysiologically, a less complex retinal micro-
vascular network is a result of retinal vessel rarefaction
and collapse, which may cause retinal hypoxia [34].
Destruction and obstruction of the small perforating cere-
bral vessels have been reported [35] indicating that corre-
sponding pathologic mechanisms are responsible for
microvascular changes in the retina and brain. These find-
ings provide evidence for the role of microvascular pathol-
ogy in the development of dementia. However, the effect
sizes reported here are small to medium (d 5 0.2–0.4). In
the largest study, the association of arteriolar fractal anal-
ysis was lost in the fully adjusted model [28]. Potential dif-
ferences between arteriolar and venular fractal networks
should be assessed using data from larger studies and in
different patient populations.
Vessel caliber measurements present conflicting results;
both narrower [10,26] and wider arterioles [28] were associ-
ated with AD. The finding of narrower venules in AD [10,26]
was not replicated by Williams et al. [28]. The prospective
Rotterdam Study found wider venular calibers were related
to an increased risk of dementia, largely driven by the asso-
ciation with risk of VaD [24]. The association between nar-
rower arteriolar caliber and AD in the Singapore
Epidemiology of Eye Disease program study was lost after
adjustment for cardiovascular risk factors [10]. Narrower ar-
terioles are strongly associated with hypertension [11,36],
which could be responsible for the attenuation in
association. Wider retinal venules in VaD could reflect
inflammation, cerebral hypoperfusion, and subsequent
ischemia, whereas narrower venules in AD may reflect
increased venular wall thickness as a result of collagen
deposition in cerebral veins [37]. However, evidence has
also been reported supporting the involvement of1 December 2016  11:02 pm  ce
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1692inflammation in the development of AD [38]. It is possible
that opposing changes in diameter caused by inflammation
and collagen deposition may decrease the likelihood of de-
tecting meaningful changes and effects. The different mech-
anisms underlying the association of changes to arteriolar
and venular caliber emphasize the importance of analyses
according to dementia subtypes and in adjusting for the
opposing effect of fellow vessel caliber. Contrasting effects
of hypertension causing arteriolar narrowing and ischemia
and endothelial dysfunction causing arteriolar widening
may lead to spurious associations of vessel caliber with de-
mentia. No association between arteriolar caliber and VaD
was found until venular calibers were adjusted for [24].
Most studies adjusted for the opposing effects of fellow
vessel caliber [10,24,28]. Frost et al. [26] do not report ad-
justing for opposing vessel type. Inconsistent associations
of vessel caliber could also be attributed to natural variation
because of pulsation during the cardiac cycle and by vaso-
motion with arteriolar and venular caliber found to vary by
up to 17% and 11%, respectively [39].
Tortuosity has been proposed as a means of identifying
those at risk ofmicrovascular complications by detecting initial
vascular changes [28,40]. Results were inconsistent with both
increased [10] and decreased tortuosity [26,28] associated
with AD. Although the underlying mechanisms for its onset
and development remain unclear, retinal tortuosity has been
associated with hypertension, retinopathy, cerebral vessel
disease, stroke, and ischemic heart disease [18,41–43]. The
finding of increased tortuosity in AD is in line with previous
findings in stroke, hypertension, and cerebrovascular disease
[40,44,45]. Reduced tortuosity has been associated with
increasing risk of death from ischemic heart disease possibly
resulting from endothelial dysfunction and a widespread
impairment of perfusion or oxygenation in the
microvasculature [42]. Reduced arteriolar tortuosity has also
been found in diabetic retinopathy [17]. The accuracy of tortu-
osity measurement may be related to the length of the vessel
segments [46]. For example, when assessing tortuosity of an
entire vessel segment labeled as tortuous, smaller straight
(i.e., less tortuous) subsectionswithin the segmentmay compli-
cate classification by influencing the overall tortuosity of the
vessel making it appear less tortuous. All three studies used
SIVA to calculate tortuosity where automatically segmented
vessels are typically short enough to be classed as either
entirely tortuous or nontortuous. Short-term changes in tortuos-
ity in response to environmental effects have also been reported
[47]. Tortuosity discrepancies may also be because of differ-
ences in race between the studies (Chinese, Indian, and Malay
in the Cheung et al. study [10] vs. white Caucasians in Frost
et al. [26] and Williams et al. [28]).
Retinopathy lesions including microaneurysms and
retinal hemorrhages reflect a breakdown of the retinal blood
barrier [48,49]. Results from cross-sectional [23,25] andREV 5.4.0 DTD  DADM132_proof longitudinal studies [25] suggest that although a marker of
microvascular pathology retinopathy is more prevalent in
dementia, the onset does not precede the development of de-
mentia. Although retinopathy may reflect underlying cere-
bral vascular pathology, it is more likely to reflect
advanced cerebral microvascular states and as such may
not be useful as a diagnostic tool or biomarker for risk of
development, as the condition is unlikely to develop before
the clinical stages of dementia [25]. The inconsistent find-
ings could reflect the different definitions and grading of reti-
nopathy across studies. Although the three studies mostly
used common features for diagnosis, it is noteworthy that
the only study failing to identify a significant association
used the most comprehensive range of retinopathy signs
including intraretinal microvascular abnormalities, venous
beading, vitreous hemorrhage, and new vessels at the disc
or elsewhere [21]. Neither cross-sectional nor longitudinal
associations between AMD and dementia were found
[20,22,27].
An additional motivation of this review was to estab-
lish whether fundus image analysis could differentiate
between dementia subtypes. Most studies meeting the in-
clusion criteria focused exclusively on AD [10,20,26–28]
with limited numbers of VaD across studies (n 5 102).
The few studies with sufficient numbers for stratified
analysis revealed different outcomes by diagnosis:
larger venular calibers associated with increased risk of
VaD but not with AD [24]; FAN was associated with
mixed AD VaD but not with AD [21]; and retinopathy
was associated with AD but not with VaD [25] with the
opposite finding for Qiu et al. [23]. Although the limited
number of cases of VaD (n 5 29) could explain the insig-
nificant association in the Rotterdam Study [25], results
provide some evidence of the utility of fundus imaging
in the differentiation of dementia subtypes. Fundus imag-
ing should be applied to assess the role of microvascular
pathology in larger samples of other forms of dementia,
particularly VaD.
Accurate and meaningful interpretation of retinal param-
eters requires not only precise quantification and calculation
but also an understanding of potential effects of axial length
and ocular refractive error. Dimensional parameters such as
CRAE and CRVE are subject to magnification effects and
refractive error. The Blue Mountains Eye Study and Beaver
Dam Eye Study found an association between myopic
refraction and reduced retinal FD and smaller retinal vessel
diameters, respectively [50,51]. The Blue Mountains Eye
Study found that correcting for refractive error appeared to
increase the statistical power to detect associations with
retinal vessel caliber [51]. Only one study reviewed adjusted
for magnification effects using refractive data [24]. Data on
axial length were not included in the reviewed studies.
Longer axial length has been associated with the narrowing1 December 2016  11:02 pm  ce
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1817of arterioles and venules, increased arteriolar and venular
BCs, and less tortuous arterioles [52]. Patton et al. [53] like-
wise found an association between increased axial length
and narrowing of retinal vessels. No effect of axial length
on AVR, junctional exponents, and bifurcation angles was
found. Future studies using dimensional measures should
adjust for refraction and axial length. Dimensionless mea-
sures that are not subject to the influence of these effects
such as AVR, junction exponent, tortuosity, and LDRs
have been calculated.
Most of the quantitative measurements were assessed and
calculated using the same semiautomated software, SIVA.
Despite using the software according to the standardized pro-
tocol to measure common retinal vascular properties in
similar patient groups, results were inconsistent [10,26,28].
Moderate to high intergrader reliability of quantitative
measurements using SIVA has been reported with
coefficient of variations ranging from 1.76% for venular
caliber to 17.66% for venular tortuosity [18]. In addition to
SIVA, a number of software packages are available (e.g.,
VAMPIRE [54], ARIA [55], IVAN [University of Wisconsin,
Madison]), each implementing different algorithms for detec-
tion and measurement of retinal vascular features. Although
the uniformity of quantitative retinal measurement methods
in the reviewed studies facilitates comparison, additional
studies using different software and measurement methods
are required to provide a more comprehensive view of retinal
vascular status in dementia. Furthermore, a comparison of
retinal vascular parameters measured using the same fundus
images with different software packages is required.
Some methodological issues warrant consideration, chiefly
the limited number and heterogeneity of reviewed studies,
including design, population, covariates, retinal parameters,
and outcome measures. The review of the association between
many retinal parameters and dementia was therefore restricted
to a descriptive comparison. In addition, studies with negative
findings may be under-represented because of publication bias.
The studies reviewed neither report dementia severity nor do
they include histopathologic confirmation of diagnosis.
Different levels of disease severity and diagnostic inaccuracy
could account for some of the inconsistencies between studies.
Although all used standard clinical diagnosis criteria, studies
have shown these criteria to routinely fail in accurately differ-
entiating between AD and non-AD dementia [56]. A study of
15,367 patients found that 16.6% of patients with VaD were
misdiagnosed with AD [57]. It is possible that the AD samples
in the studies reviewed include patients withVaD,whichwould
introduce variability to the outcomes. Studies also vary in the
range and breadth of potentially confounding variables
adjusted for which affects outcomes and their interpretation.
Participants with ungradable retinal photographs were
excluded from most studies. Excluded participants were
more likely to have vascular risk factors [21,22,24]. Because
of the association of these risk factors with both dementia
and retinal abnormalities the observed associations may have
been falsely attenuated as a result of selection bias.REV 5.4.0 DTD  DADM132_proof Although not wholly consistent, the findings of this
review provide evidence to support the hypothesis that
changes in retinal microvasculature identified using
fundus imaging are associated with dementia. The mea-
surement of retinal microvasculature, particularly FD,
using fundus camera imaging appears to offer a prom-
ising means of noninvasively identifying retinal micro-
vascular abnormalities associated with dementia.
However, the strength of the relation between retinal
microvascular properties and dementia is modest, which
limits the prognostic value at the population level. Yet,
imaging the retinal microvasculature may be used to in-
crease understanding of the mechanisms underlying the
pathogenesis of dementia, provide enhanced differentia-
tion of dementia subtypes, and as a potential means of
improving detection of those at an increased risk of de-
mentia. Future research should explore the diagnostic
and prognostic contribution of combining measures of
the retinal vasculature with other clinical and imaging
biomarkers in a multimodal approach, for example, met-
rics derived from retinal OCT. Analysis of combined
retinal vascular parameters (e.g., vessel calibers, FD,
and tortuosity), instead of individual markers, may also
provide increased sensitivity and specificity for different
subtypes of dementia. In addition, dynamic functional
measures of retinal microcirculation including flowmetry
[58], retinal oximetry [59], and dynamic vessel assess-
ments [60] could provide further valuable insights into
cerebral hemodynamics in dementia. Greater measure-
ment harmonization between studies with a consensus
on standards for scientific reporting of retinal microvas-
cular changes related to dementia is required. Measures
taken to optimize image analysis through the introduc-
tion of standard operating procedures related to imaging
techniques, camera systems, and measurement could
help to reduce the variability and increase the clinical
utility of retinal imaging. Further studies with common
objective and standardized retinal measurements are
required in larger samples of patients with different
forms of dementia to increase understanding of the spec-
ificity of retinal microvascular abnormalities. In addi-
tion, more prospective data are needed to determine the
most appropriate parameters for application as diag-
nostic tools or biomarkers for risk of development of de-
mentia. These issues need to be addressed before a
conclusion on the true clinical utility of fundus camera
imaging in dementia can be reached.Acknowledgments
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1939RESEARCH IN CONTEXT
1. Systematic review: We searched Medical Literature
Analysis and Retrieval System Online, Excerpta
Medica Database, PubMed, and Google Scholar for
all human studies published until March 2016.
Studies were systematically evaluated and meta-
analysis of pooled results was performed.
2. Interpretation: This is the most comprehensive sys-
tematic review focusing specifically on the use of
fundus camera imaging in dementia. Significant
pathologic changes in retinal parameter were found.
Results across studies were inconsistent potentially
because of varied methodologies applied and the
lack of standardized methods and measurements.
3. Future directions: The potential of fundus camera
image analysis in differentiating between dementia
subtypes should be the subject of further research
of larger well-powered samples of well-
characterized dementia types with sufficient
numbers for stratified analyses. A particular focus on
VaD is warranted because of previous findings of an
association of retinal vessel width and major risk
factors for VaD, cerebral small vessel disease, and
stroke.
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